A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2018
At a glance
- Drugs IDP 124 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Bausch Health Companies; Ortho Dermatologics
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 02 May 2018 Planned End Date changed from 1 Apr 2018 to 1 Mar 2019.
- 02 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Feb 2019.